Plain-English translation of NCT07321886 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called to see if it can help adults with obesity or overweight lose weight. You would receive a weekly injection under your skin, and researchers would compare how well the medication works compared to a placebo (a dummy injection with no active medicine). The goal is to understand whether this treatment is safe and effective for people who have tried to lose weight through diet alone.
Many people struggle to lose weight through diet and exercise alone, and current treatment options are limited. This trial exists to see if this new weekly medication could offer another tool to help people manage their weight and reduce related health problems like high blood pressure and heart disease.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would give yourself a weekly injection under your skin — similar to how some people self-inject insulin or other medications at home. The main phase of the study lasts about 75 weeks (roughly 18 months), and you would visit the clinic regularly so researchers can track your weight, overall health, and any side effects. If you have prediabetes, you would continue in an additional 2-year extension phase. Half of participants will receive the active medication, and half will receive a placebo, determined randomly.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States